Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Cholesterol Ester Storage Disease(CESD)
View Full LandscapeTarget Indication
Cholesterol Ester Storage Disease(CESD)
Clinical Trial
NCT01307098Last updated: 5/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Kanuma
Kanuma is indicated for long-term enzyme replacement therapy (ERT) in patients of all ages with lysosomal acid lipase (LAL) deficiency.